The long non-coding RNA landscape in juvenile myelomonocytic leukemia
Language English Country Italy Media print-electronic
Document type Letter, Research Support, Non-U.S. Gov't
PubMed
29858388
PubMed Central
PMC6278979
DOI
10.3324/haematol.2018.189977
PII: haematol.2018.189977
Knihovny.cz E-resources
- MeSH
- Child MeSH
- Leukemia, Myelomonocytic, Juvenile genetics metabolism pathology MeSH
- Humans MeSH
- Child, Preschool MeSH
- Gene Expression Regulation, Leukemic * MeSH
- RNA, Long Noncoding biosynthesis genetics MeSH
- RNA, Neoplasm biosynthesis genetics MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- RNA, Long Noncoding MeSH
- RNA, Neoplasm MeSH
Cancer Research Institute Ghent Belgium
Center for Medical Genetics Ghent University Hospital Belgium
Department of Clinical Chemistry Microbiology and Immunology Ghent University Belgium
Department of Genetics University Hospital of Robert Debré and Paris Diderot University Paris France
Department of Pediatrics Aarhus University Hospital Skejby Aarhus Denmark
Department of Women and Child Health University of Padova Italy
Dutch Childhood Oncology Group The Hague the Netherlands
Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands
See more in PubMed
Niemeyer CM. RAS diseases in children. Haematologica. 2014; 99(11):1653–1662. PubMed PMC
Locatelli F, Niemeyer CM. How I treat juvenile myelomonocytic leukemia. Blood. 2015; 125(7):1083–1090. PubMed
Stieglitz E, Taylor-Weiner AN, Chang TY, et al. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015; 47(11):1326–1333. PubMed PMC
Caye A, Strullu M, Guidez F, et al. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. Nat Genet. 2015; 47(11):1334–1340. PubMed
Helsmoortel HH, Bresolin S, Lammens T, et al. LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia. Blood. 2016; 127(9):1163–1172. PubMed
Lipka DB, Witte T, Toth R, et al. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nature Commun. 2017; 8(1):2126. PubMed PMC
Stieglitz E, Mazor T, Olshen AB, et al. Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia. Nature Commun. 2017; 8(1):2127. PubMed PMC
Volders PJ, Helsens K, Wang X, et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res. 2013; 41(Database issue):D246–251. PubMed PMC
Bhan A, Soleimani M, Mandal SS. Long Noncoding RNA and Cancer: A New Paradigm. Cancer Res. 2017;77(15):3965–3981. PubMed PMC
Schwarzer A, Emmrich S, Schmidt F, et al. The non-coding RNA landscape of human hematopoiesis and leukemia. Nature Commun. 2017; 8(1):218. PubMed PMC
Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005; 102(43):15545–15550. PubMed PMC
Garzon R, Volinia S, Papaioannou D, et al. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proc Natl Acad Sci USA. 2014;111(52):18679–18684. PubMed PMC
Addelman S. The Generalized Randomized Block Design. Am Stat. 1969; 23(4):35–36.
Lee S, Seo HH, Lee CY, et al. Human Long Noncoding RNA Regulation of Stem Cell Potency and Differentiation. Stem Cells Int. 2017;2017:6374504. PubMed PMC
Bresolin S, Zecca M, Flotho C, et al. Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia. J Clin Oncol. 2010; 28(11):1919–1927. PubMed
